cholest-4-en-3-one, oxime

cholest-4-en-3-one, oxime
Trade Name
Orphan Indication Spinal muscular atrophy
USA Market Approval USA
USA Designation Date 2009-02-17 00:00:00
Sponsor Genentech, Inc.;A Roche Group Member, 1 DNA Way;South San Francisco, California, 94080